Hematoxylin and eosin staining of allograft particulate implanted in 3-mm femoral defects at 10 weeks postoperatively.

Donor Bisphosphonate Treatment Negatively Impacts Mineralized Allografts, Animal Study Finds

The findings of a new animal study suggest that bisphosphonate treatment in donors may indeed be relevant when mineralized allografts are used in orthopaedic procedures. Editor-in-Chief Dr. Marc Swiontkowski discusses this new JBJS report.  


The worldwide orthopaedic community has been